argus

Alkem Laboratories Limited

NSE: ALKEMINE540L0101462,293 Cr

Timeline

Time (IST)TypeMEventSrc
20 May, 03:45 pmAlkem Laboratories Limited has informed the Exchange about Conference Call on Q4FY26 and FY26.nse
19 May, 02:55 pmAlkem Laboratories Ltd - 539523 - Board Meeting Intimation for Board Meeting Intimation For Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 28Th May, 2026.bse
18 May, 12:35 pmAlkem Laboratories Limited has informed the Exchange about appointment of Senior Management Personnelnse
18 May, 12:34 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
08 May, 06:38 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated May 08, 2026, titled "This is to Inform you regarding US FDA inspection conducted today at the Company'' s CRO facility located at Taloja.".nse
08 May, 06:22 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
05 May, 06:50 pmAlkem Laboratories Ltd - 539523 - Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.bse
05 May, 06:48 pmAlkem Laboratories Limited has informed the Exchange about favourable Order-in-Appeal passed by statutory authority under the Goods and Services Tax Act, 2017nse
02 May, 12:52 pmAlkem Laboratories Limited has informed the Exchange about US FDA Inspection at Company s manufacturing facility located at Amaliya, Damannse
24 Apr, 04:42 pmAlkem Laboratories Limited has informed the Exchange that the Company has received an order passed by statutory authority under the Income-tax Act, 1961nse
24 Apr, 04:36 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')bse
24 Apr, 03:28 pmAlkem Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMPnse
24 Apr, 02:33 pmAlkem Laboratories Limited has informed the Exchange about Change in Key Managerial Personnel Resignation of Chief Executive Officernse
24 Apr, 02:26 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Cessationbse
13 Apr, 03:38 pmAlkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Incorporation Of Wholly Owned Subsidiary Of The Companybse
13 Apr, 03:37 pmAlkem Laboratories Limited has informed the Exchange about incorporation of Wholly Owned Subsidiary of the Company in Dubai, UAE.nse
10 Apr, 06:02 pmThe Exchange had sought clarification from Alkem Laboratories Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.nse
07 Apr, 03:30 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
07 Apr, 03:26 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Alkem launches A to Z Daily, an everyday multivitamin supplement for body and mind".nse
07 Apr, 02:30 pmBasudeo N. Singh has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
02 Apr, 12:59 pmAlkem Laboratories Limited has informed the Exchange about increase in investment to be made for setting up of manufacturing facility of the Company in Ujjain, Madhya Pradesh.nse
31 Mar, 06:47 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
31 Mar, 06:46 pmAlkem Laboratories Limited has informed the Exchange change in Senior Managementnse
30 Mar, 05:44 pmAlkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Incorporation Of Wholly Owned Subsidiary Of The Company As A ''Scientific Office''.bse
30 Mar, 05:36 pmAlkem Laboratories Limited has informed the Exchange about Intimation for incorporation of Wholly Owned Subsidiary of the Company as a Scientific Officense
27 Mar, 06:16 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
27 Mar, 06:09 pmAlkem Laboratories Limited has informed the Exchange regarding Appointment of Mr Samsher Kumar Deo as Senior Management Personnel of the company w.e.f. March 27, 2026.nse
21 Mar, 12:27 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
21 Mar, 12:16 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Alkem Laboratories launches Semaglutide injection in India, with weekly therapy starting at INR 450/- ".nse
20 Mar, 09:26 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
20 Mar, 09:18 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated March 20, 2026, titled "Intimation regarding receipt of EU GMP Certificate for the Company s manufacturing facility located at Daman, India".nse
18 Mar, 07:56 pmAlkem Laboratories Limited has informed the Exchange regarding Intimation for allotment of land for setting up of a greenfield formulation manufacturing facility of the Company in Ujjain, MP.nse
18 Mar, 07:52 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 As Amendedbse
14 Mar, 03:45 pmAlkem Laboratories Limited has informed the Exchange about receipt of EU GMP Certificate for the Company s manufacturing facility located at Baddi, India.nse
06 Mar, 03:41 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
06 Mar, 03:37 pmAlkem Laboratories Limited has informed the Exchange about Updates on Acquisition.nse
20 Feb, 06:34 pmAlkem Laboratories Ltd - 539523 - Investor Meet On Alkem Medtech'S Strategic Way Forward - Video Recording.bse
20 Feb, 06:31 pmAlkem Laboratories Limited has informed the Exchange about Link of Recordingnse
18 Feb, 12:58 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
18 Feb, 12:52 pmAlkem Laboratories Limited has informed the Exchange about Investor Presentationnse
16 Feb, 07:44 pmAlkem Laboratories Limited has informed the Exchange about Investor Presentationnse
16 Feb, 07:38 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
16 Feb, 05:22 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
16 Feb, 05:13 pmAlkem Laboratories Limited has informed the Exchange about Transcriptnse
16 Feb, 03:03 pmAlkem Laboratories Limited has informed the Exchange about USFDA inspection at the manufacturing facility of Enzene Biosciences Limited, a subsidiary of the Company in India located at Chakan, Punense
14 Feb, 12:02 pmAlkem Laboratories Limited has informed the Exchange about USFDA inspection at the manufacturing facility of Enzene Biosciences Limited, a subsidiary of the Company in Indianse
13 Feb, 07:39 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Feb, 07:35 pmAlkem Laboratories Limited has informed the Exchange about Link of Recordingnse
13 Feb, 02:38 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release".nse
13 Feb, 02:36 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse